Black Friday saleUp to 70% OFF
333

REMED CO.,LTD.

No trades
See on Supercharts
Overview
Financials Discussions Technicals Seasonals

302550 chart


Full chart

Key stats


Market capitalization
‪118.88 B‬ KRW
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
25
Basic EPS (TTM)
160 KRW
Net income (FY)
‪797.17 M‬ KRW
Revenue (FY)
‪18.54 B‬ KRW
Shares float
‪17.78 M‬
Beta (1Y)
0.39

Employees


Employees (FY)
114
Change (1Y)
−1 −0.87%
Revenue / Employee (1Y)
‪124.88 K‬ KRW
Net income / Employee (1Y)
‪5.37 K‬ KRW

About REMED CO.,LTD.


Sector
Health Technology
Industry
Medical Specialties
CEO
Geun-Yong Lee
Website
remed.kr
Headquarters
Daejeon
Founded
2003
ISIN
KR7302550009
FIGI
BBG00LNLYGM4
REMED Co., Ltd. engages in the development and manufacture of medical devices related to electronic medication. The firm focuses on brain rehabilitation business that utilizes Transcranial Magnetic Stimulation for the purpose of non-invasive treatment and rehabilitation of brain diseases. It also specializes in chronic pain treatment business using Neuro Magnetic Stimulation and an aesthetic business using Core Muscle Strengthen Magnetic Stimulation to strengthen muscles. The company was founded on July 31, 2003 and is headquartered in Daejeon, South Korea.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

Technicals

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of 302550 is 3,755 KRW — it has decreased by −0.39% in the past 24 hours. Watch REMED CO.,LTD. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange REMED CO.,LTD. stocks are traded under the ticker 302550.
302550 stock has fallen by −0.51% compared to the previous week, the month change is a 13.45% rise, over the last year REMED CO.,LTD. has showed a 11.62% increase.
302550 reached its all-time high on Jun 11, 2020 with the price of 7,910 KRW, and its all-time low was 2,030 KRW and was reached on Oct 13, 2022. View more price dynamics on 302550 chart.
See other stocks reaching their highest and lowest prices.
302550 stock is 8.17% volatile and has beta coefficient of 0.39. Track REMED CO.,LTD. stock price on the chart and check out the list of the most volatile stocks — is REMED CO.,LTD. there?
Today REMED CO.,LTD. has the market capitalization of ‪118.88 B‬, it has decreased by −0.64% over the last week.
Yes, you can track REMED CO.,LTD. financials in yearly and quarterly reports right on TradingView.
302550 net income for the last quarter is ‪3.64 B‬ KRW, while the quarter before that showed ‪1.07 B‬ KRW of net income which accounts for 240.52% change. Track more REMED CO.,LTD. financial stats to get the full picture.
No, 302550 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 25, 2024, the company has 114.00 employees. See our rating of the largest employees — is REMED CO.,LTD. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. REMED CO.,LTD. EBITDA is ‪1.67 B‬ KRW, and current EBITDA margin is −10.28%. See more stats in REMED CO.,LTD. financial statements.
Like other stocks, 302550 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade REMED CO.,LTD. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So REMED CO.,LTD. technincal analysis shows the neutral today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating REMED CO.,LTD. stock shows the buy signal. See more of REMED CO.,LTD. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.